Impact and effective management of nausea/vomiting on patients treated with zolbetuximab + chemotherapy: insights from the phase III SPOTLIGHT and GLOW studies.
- DOI
- 10.1016/j.esmoop.2025.105931
- Published
- 2026 Feb
- Container
- ESMO open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.esmoop.2025.105931,
title = {Impact and effective management of nausea/vomiting on patients treated with zolbetuximab + chemotherapy: insights from the phase III SPOTLIGHT and GLOW studies.},
author = {Shitara K and Smyth E and Lordick F and Pophale R and Matney C and Matsangou M and Gourgioti G and Oh M and Ranganath R and Klempner SJ},
year = {2026},
journal = {ESMO open},
doi = {10.1016/j.esmoop.2025.105931},
url = {https://doi.org/10.1016/j.esmoop.2025.105931}
}RIS
TY - JOUR TI - Impact and effective management of nausea/vomiting on patients treated with zolbetuximab + chemotherapy: insights from the phase III SPOTLIGHT and GLOW studies. AU - Shitara K AU - Smyth E AU - Lordick F AU - Pophale R AU - Matney C AU - Matsangou M AU - Gourgioti G AU - Oh M AU - Ranganath R AU - Klempner SJ PY - 2026 JO - ESMO open DO - 10.1016/j.esmoop.2025.105931 UR - https://doi.org/10.1016/j.esmoop.2025.105931 ER -
APA
K, S., E, S., F, L., R, P., C, M., M, M., G, G., M, O., R, R., & SJ, K. (2026). Impact and effective management of nausea/vomiting on patients treated with zolbetuximab + chemotherapy: insights from the phase III SPOTLIGHT and GLOW studies.. ESMO open. https://doi.org/10.1016/j.esmoop.2025.105931
Source records
- pubmed · retrieved 2026-09-26T16:45:10.064Z